MIR5692C1: A Drug Target / Disease Biomarker (G100847082)
MIR5692C1: A Drug Target / Disease Biomarker
MIR5692C1, a protein found in the bloodstream, has been identified as a potential drug target or biomarker for various diseases, including cancer, cardiovascular diseases, and neurodegenerative disorders.
The protein MIR5692C1 is a member of the immunoglobulin superfamily, which includes antibodies, adaptins, and other proteins that play a critical role in the immune system. MIR5692C1 is a single-chain protein with a molecular weight of approximately 120 kDa. It is expressed in a variety of tissues and cells in the body, including blood cells, tissues, and organs.
One of the key functions of MIR5692C1 is its role in the immune response. MIR5692C1 is a receptor for antigens, which are molecules that the body recognizes as foreign and creates an immune response to remove the foreign substance. MIR5692C1 is involved in the development and regulation of an immune response that is critical for protecting the body against infection, disease, and cancer.
In addition to its role in the immune system, MIR5692C1 has also been shown to play a critical role in the development and progression of various diseases. For example, MIR5692C1 has been shown to be overexpressed in a variety of cancer tissues, including breast cancer, lung cancer, and colorectal cancer. This suggests that MIR5692C1 may be a promising target for cancer therapies.
MIR5692C1 has also been shown to be involved in the development of cardiovascular diseases. For example, MIR5692C1 has been shown to be expressed in the blood vessels of individuals with hypertension, which is a common cause of cardiovascular disease. This suggests that MIR5692C1 may be a potential target for therapies aimed at reducing blood pressure and reducing the risk of cardiovascular disease.
In addition to its potential role in cancer and cardiovascular diseases, MIR5692C1 has also been shown to be involved in the development and progression of neurodegenerative disorders. For example, MIR5692C1 has been shown to be expressed in the brain and spinal cord of individuals with Alzheimer's disease, which is a common form of neurodegenerative disorder. This suggests that MIR5692C1 may be a potential target for therapies aimed at treating neurodegenerative disorders.
In conclusion, MIR5692C1 is a protein that has been shown to play a critical role in the immune system, cancer, cardiovascular diseases, and neurodegenerative disorders. Its potential as a drug target or biomarker makes it an attractive target for further research and development. Further studies are needed to fully understand the role of MIR5692C1 in these diseases and to develop effective therapies aimed at treating them.
Protein Name: MicroRNA 5692c-1
More Common Targets
MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697 | MIR5698 | MIR5699 | MIR570 | MIR5700 | MIR5701-1 | MIR5701-2 | MIR5701-3 | MIR5702 | MIR5703 | MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG | MIR571 | MIR572 | MIR573 | MIR5739 | MIR574 | MIR575 | MIR576 | MIR577 | MIR578 | MIR5787 | MIR579 | MIR580 | MIR581 | MIR582 | MIR583 | MIR584 | MIR585 | MIR586 | MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603 | MIR604 | MIR605 | MIR606 | MIR6068 | MIR6069 | MIR607 | MIR6070 | MIR6071 | MIR6072 | MIR6073 | MIR6074 | MIR6075 | MIR6076 | MIR6077 | MIR6078 | MIR608 | MIR6080 | MIR6081 | MIR6082 | MIR6083 | MIR6084 | MIR6085 | MIR6086 | MIR6088 | MIR6089 | MIR609 | MIR6090 | MIR610 | MIR611 | MIR612 | MIR6124 | MIR6125 | MIR6126 | MIR6127 | MIR6128 | MIR6129 | MIR613 | MIR6130 | MIR6131 | MIR6132 | MIR6133 | MIR6134 | MIR614 | MIR615
